Early statin therapy restores endothelial function in children with familial hypercholesterolemia.

[1]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[2]  Ncep Expert Panel on Blood Cholesterol Levels in Childr Adolescents.  National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. , 1992, Pediatrics.

[3]  T. Farag.  Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.

[4]  M. Trip,et al.  Familial hypercholesterolemia in children , 2004, Current opinion in lipidology.

[5]  R. Vogel.  Cholesterol lowering and endothelial function. , 1999, The American journal of medicine.

[6]  L. Wilkins.  Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  M. Malloy,et al.  Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy. , 1998, The Journal of pediatrics.

[8]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[9]  J. Kastelein,et al.  [Higher prevalence of familial hypercholesterolemia than expected in adult patients of four family practices in Netherlands]. , 2000, Nederlands tijdschrift voor geneeskunde.

[10]  F. Ohsuzu,et al.  Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. , 1998, The American journal of cardiology.

[11]  J. Kastelein,et al.  Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. , 2002, Atherosclerosis.

[12]  T. Rabelink,et al.  Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication , 1995, The Lancet.

[13]  A. Takeshita,et al.  Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin). , 2001, The American journal of cardiology.

[14]  M. Hijmering,et al.  Variability of flow mediated dilation: consequences for clinical application. , 2001, Atherosclerosis.

[15]  R. Reneman,et al.  An integrated system for the non-invasive assessment of vessel wall and hemodynamic properties of large arteries by means of ultrasound. , 1999, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[16]  E. Benjamin,et al.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.

[17]  H. Büller,et al.  Short-Term Efficacy and Safety of Pravastatin in 72 Children with Familial Hypercholesterolemia , 1996, Pediatric Research.

[18]  J. Ross,et al.  Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein. , 2001, Journal of the American College of Cardiology.

[19]  P. Hopkins,et al.  Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. , 1999, JAMA.

[20]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[21]  J. Kjekshus,et al.  Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients. , 2001, The American journal of cardiology.

[22]  J. Albers,et al.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. , 1978, Journal of lipid research.

[23]  A. Yeung,et al.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.

[24]  K. Kostner,et al.  Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. , 2000, The American journal of cardiology.

[25]  J. T. Clarke,et al.  Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. , 1996, Pediatrics.

[26]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[27]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Circulation.

[28]  W. Weintraub,et al.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.

[29]  A. Yeung,et al.  Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. , 2000, Circulation.

[30]  J. Strong,et al.  Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth. , 2000, Circulation.

[31]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[32]  C. Napoli,et al.  Nitric oxide and atherosclerosis. , 2001, Nitric oxide : biology and chemistry.

[33]  E. Mannarino,et al.  Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women. , 2000, Journal of cardiovascular pharmacology.

[34]  C. Lau,et al.  Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients , 1993, The Lancet.